David Sinclair skips breakfast, eats once or twice a day, and has publicly discussed his fasting approach for years. His Lifespan podcast episode on fasting went viral in 2026. Here's what the actual science says about fasting and aging.
David Sinclair's Lifespan podcast episode on fasting gained tens of thousands of views in its first week of release. The reason is straightforward: Sinclair is a Harvard genetics professor who has been publishing longevity research for 20 years, and fasting is one of the few interventions with reproducible lifespan data across multiple species. When Sinclair discusses it, he's drawing on a specific mechanistic framework that goes well beyond the typical weight-loss framing.
Here is what the science actually says about fasting and aging, why Sinclair's framework is compelling, and what a practical fasting protocol looks like for longevity specifically.
Sinclair's information theory of aging holds that aging is fundamentally a loss of epigenetic information — the cellular "software" that tells genes when to turn on and off. Fasting is, in his framework, one of the most powerful tools for restoring this information by activating the longevity-associated pathways that evolution created for times of scarcity.
The key nutrient-sensing pathways are:
mTOR (mechanistic target of rapamycin): When amino acids and energy are abundant, mTOR promotes cell growth, protein synthesis, and proliferation. When nutrients are restricted, mTOR is suppressed. Lower mTOR activity during fasting triggers autophagy — the cellular cleanup process that breaks down and recycles damaged proteins and organelles. Autophagy is increasingly understood as a core anti-aging mechanism.
AMPK (AMP-activated protein kinase): The cellular energy sensor. When energy is low (fasting, exercise), AMPK is activated, triggering mitochondrial biogenesis, glucose uptake, and — importantly — sirtuin activation. Sirtuins, the family of proteins Sinclair's lab has studied for two decades, require both NAD+ and AMPK signaling to function optimally.
Sirtuins (SIRT1–7): Gene regulators that use NAD+ to deacylate histones and other proteins, influencing gene expression across the epigenome. During fasting, SIRT1 and SIRT3 (the mitochondrial sirtuin) are activated and act as master regulators of metabolic adaptation. Sinclair views sirtuin activation as central to the longevity benefits of fasting.
IGF-1 / insulin signaling: Fasting reduces insulin and IGF-1, which are growth and cell-division signals. Lower IGF-1 is consistently associated with longevity in model organisms (the *C. elegans* daf-2 mutants, dwarf mice), and caloric restriction consistently lowers IGF-1 in animals. The translation to humans is more complex.
Caloric restriction — reducing food intake by 20–40% without malnutrition — remains the most robust lifespan-extending intervention in animal models. It has extended lifespan in yeast, worms, flies, mice, and rats. The Wisconsin National Primate Research Center's caloric restriction study in rhesus monkeys showed a 30% reduction in age-related disease incidence and substantially longer median survival.
Intermittent fasting (time-restricted eating, alternate-day fasting) appears to activate many of the same pathways as caloric restriction even when total caloric intake is not reduced, though the lifespan data in animals is more mixed than for true caloric restriction.
Sinclair has described his eating pattern publicly in interviews and on the podcast:
The fasting component is time-restricted eating (TRE) rather than alternate-day fasting or multi-day fasts. His argument for doing it in the morning (rather than evening) is partly practical (social dinners) and partly mechanistic (morning fasting coincides with circadian biology and lower insulin sensitivity).
Time-restricted eating (TRE): A 2022 *New England Journal of Medicine* trial (TREAT trial, 18 weeks) found that TRE (8-hour eating window) produced modest weight loss (–0.94 kg) compared to unrestricted eating, but no significant difference in metabolic markers. The Early TRE trials (front-loading calories to the morning) show more metabolic benefit than late TRE. A 2023 trial in adults with metabolic syndrome found 8-hour TRE reduced insulin resistance and inflammatory markers.
Fasting-mimicking diet (FMD): Valter Longo's 5-day low-calorie protocol that mimics fasting biochemically. Three cycles in a *Science Translational Medicine* trial reduced metabolic disease risk factors and lowered IGF-1 by ~15%.
Human lifespan data: Direct evidence that fasting extends human lifespan does not exist — no randomized trial has run long enough or measured mortality directly. The longevity case rests on mechanism (we understand how fasting activates longevity pathways), animal data (remarkably consistent), and epidemiology (Blue Zone populations tend to eat less, with lower meal frequency).
Sinclair's framework is actionable. The core elements:
1. 12–16 hour daily fast (time-restricted eating). The simplest version: stop eating by 8 PM, don't eat again until 8 AM (12-hour fast) or noon (16-hour fast). Start with 12 hours, extend if well-tolerated.
2. Black coffee or tea during the fasting window. These do not break the fast for metabolic purposes (no caloric load, no insulin response), and caffeine itself activates AMPK modestly.
3. Protein intake when you do eat. The key risk of fasting combined with aging is muscle loss (sarcopenia). Sinclair emphasizes eating enough protein within the eating window — 1.2–1.6 g/kg body weight. This is especially important as time-restricted eating can inadvertently compress protein intake.
4. Pair with exercise. Exercise activates AMPK and sirtuin pathways independently of fasting. Combined, the effects are synergistic. Morning exercise during the fasting window maximizes the AMPK/autophagy signal.
5. Consider NMN or NR supplementation. Fasting depletes NAD+ transiently (via PARP activation and increased sirtuin demand). Restoring NAD+ with oral precursors may enhance the fasting response.
The fasting-longevity connection is mechanistically strong and the animal evidence is robust. The human clinical evidence, particularly from RCTs, is real but more modest than the mechanistic story predicts — partly because we can't run 50-year mortality trials, and partly because the humans who comply perfectly with fasting protocols in studies are rare.
The practical conclusion is that consistent time-restricted eating (12–16 hours daily), paired with adequate protein intake and regular exercise, is probably beneficial for metabolic health and may genuinely influence biological aging via sirtuin and autophagy pathways. It costs nothing, carries minimal risk, and aligns with the best available longevity science.